ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE

ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE
Generic ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE
Type
Formula C12H15NO7
Weight Average: 285.25
Monoisotopic: 285.084851839
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE
ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE

Innovators Monograph

You find simplified version here ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE



https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:44419
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=150889
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444768
https://www.chemspider.com/Chemical-Structure.132992.html
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=44419
https://zinc.docking.org/substances/ZINC000006031723
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/NPF
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid
1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid
2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE
SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER
Catecholamine Tests
Shoulder MRI scan
Chest MRI
Electrocardiogram
Microalbuminuria test
Rectal culture
Nuclear ventriculography
Cortisol urine test
Ultrasound pregnancy
Dry mouth
Malignant breast disease
Temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity
Vitiligo
Attention Deficit Hyperactivity Disorder (ADHD)
Open Wound
Pharyngeal secretions
Mild Lower Urinary Tract Infection
Schizoaffective Disorders
Peripheral nerve lesion
Perioperative Blood Loss